Results 181 to 190 of about 37,295 (243)

Role of thalidomide in angiodysplasia-related gastrointestinal bleeding: a systematic review. [PDF]

Front Gastroenterol (Lausanne)
Khan J, Yousaf Shah A, Khan AA, Shahid Raja R, Ahmed Z, Shahid Raja M, Eng S, Iqbal Q.   +7 more
europepmc   +1 more source

The Rise of Regulatogens: A Crisis of Insouciance and Dilettantism in the Regulatory DART World-And How We Must Fix It. [PDF]

Birth Defects Res
DeSesso JM.
europepmc   +1 more source

In Silico Analysis of Enantioselective Binding of Pomalidomide Targets for Multiple Myeloma. [PDF]

Chirality
Vardhan G, Kumar V, Kumar A, Handu S, Dhamija P.   +4 more
europepmc   +1 more source

Case report: Pediatric vascular Behçet's disease with prominent arterial involvement: a case series of five patients. [PDF]

Front Immunol
He B, Zhang H, Ma Q, Yang Y, Chen B, Wang L, Lai J.   +6 more
europepmc   +1 more source

Sustained Remission of More Than Five Years After Thalidomide-Cyclophosphamide-Prednisone Discontinuation in Idiopathic Multicentric Castleman Disease: A Single-Center Retrospective Study [PDF]

Turk J Haematol
Dang Y, Gao Y, Li S, Zhang L, Li J.
europepmc   +1 more source

Fluorinated Aminopiperidones as Non-Glutarimide Thalidomide Analogs: Stereodivergent Synthesis and Validation. [PDF]

ChemMedChem
Adamlje B, Tomašič T, Steinebach C, Ebeling S, Herrmann A, Hartmann MD, Horner JL, Bhadresha K, Chau CH, Figg WD, Sosič I, Cotman AE.   +11 more
europepmc   +1 more source

Host-directed treatments for tuberculous meningitis utilizing a multi-platform approach across mouse and human models. [PDF]

Nat Commun
Ruiz-Gonzalez CE, Singh M, Masias-Leon Y, Chen X, Sarhan MO, Martinez-Martinez YB, Patel S, Shambles M, Villabona-Rueda A, Lissit K, Tweedie D, Scerba MT, Bishai WR, Artemov D, Xu JC, D'Alessio F, Hafner R, Greig NH, Manion M, Sereti I, Jain SK.   +20 more
europepmc   +1 more source

A classic rash and its complications. [PDF]

IDCases
Roth P, Abboy B, Kent P.
europepmc   +1 more source

[Preliminary investigation into the mechanisms of thalidomide in inhibiting the malignant transformation of oral leukoplakia]. [PDF]

Hua Xi Kou Qiang Yi Xue Za Zhi
Shang Q, Awuti G, Xu H, Chen Q, Zhao J.
europepmc   +1 more source